Optimization of Mesenchymal Stromal Cell (MSC) Manufacturing Processes for a Better Therapeutic Outcome
MSCs products as well as their derived extracellular vesicles, are currently being explored as advanced biologics in cell-based therapies with high expectations for their clinical use in the next few years. In recent years, various strategies designed for improving the therapeutic potential of mesen...
Main Authors: | Maria Eugenia Fernández-Santos, Mariano Garcia-Arranz, Enrique J. Andreu, Ana Maria García-Hernández, Miriam López-Parra, Eva Villarón, Pilar Sepúlveda, Francisco Fernández-Avilés, Damian García-Olmo, Felipe Prosper, Fermin Sánchez-Guijo, Jose M. Moraleda, Agustin G. Zapata |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.918565/full |
Similar Items
-
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study
by: Fermín Sánchez-Guijo, et al.
Published: (2020-08-01) -
Autologous mesenchymal stromal cells embedded with Tissucol Duo® for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up
by: Marcelo F. Jiménez, et al.
Published: (2023-10-01) -
Autologous adipose‐derived stem cells for the treatment of complex cryptoglandular perianal fistula: A randomized clinical trial with long‐term follow‐up
by: Mariano Garcia‐Arranz, et al.
Published: (2020-03-01) -
Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial
by: Victoria Gomez-Ruiz, et al.
Published: (2023-04-01) -
Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis
by: Juan F. Blanco, et al.
Published: (2023-03-01)